1Bode BW,Sabbah HT,Gross TM,et al.Diabetes management in the new millennium using insulin pump therapy [J].Diabetes Metab Res Rev,2002;18(supp 11 ):14-20.
2National diabetes Data Group.Diabetes in America.2 nd ed ,USA:NIH,National Institute of Diabetes and Digestive and Kidney Diseases [J].NIH Publication,1995;95:1468.
3Yoon KH,Ko SH,Cho JH,et al.selective beta cell loss and alphacell expansion in patients with type 2 diabetes mellitus in korea [J].J Clin Endocrinol Metab,2003;88(5):2300.
4Dewan S,Wilding JP.obesity and type 2 diabetes in the elderly [J].Gerontology,2003;49 (3) 137-145.
5Boden G.Pathogenesis of type 2 diabetes.Insulin resistance [J].Endocrinol Metab Clin North Am,2001;30(4) :801-815.
6Daimon M,Ji G,Saitoh T,et al.Large-scale search of SNPs for type 2 DM susceptibility genes in a Japanese population [J].Biochem Biophys Res Commun,2003;302 (4):751.
7Diabetes Control and Complications Trial Research Group (DCCT).The effect of intensive treatment of diabetes on the development and progression of long-time complications in insulin-dependent diabetes Mellitus [J].N Engl J Med,1993;329:977-986.
8UK Prospective Diabetes Study(UKPDS) Group.Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patient with type 2 diabetes [J].Lancet,1998;352:837-853.
9Jennings AM,Lewis KS,Murdoch S,et al.Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type 2 diabetic patients poorly controlled with sulfonylureas [J].Diabetes Care,1991;14:736-738.
10Home PD,Capaldo B,Burrin JM,et al.A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injection in NIDDM subjects improved control with CSII [J].Diabetes Care,1982;5:465-466.
二级参考文献25
1华琦，中华内科杂志，1997年，36卷，18页
2潘长玉，中华医学杂志，1996年，76卷，889页
3张素华，中华医学杂志，1996年，76卷，435页
4赵仲堂，疾病监测，1995年，10卷，特2期，22页
5赵本华，中国医学行为科学，1993年，2卷，13页
6蒋国彦，实用糖尿病学，1992年，40页
7郑辉，中华内分泌代谢杂志，1999年，15卷，16页
8Heekim C, Yun S K, Byun D W, et al. Codon 54 polymorphism of the fatty acid binding protein 2 gene is associated with increased fat oxidation and hyperinsulinemia, but not with intestinal fatty acid absorption in Korean men [J ]. Diabetes, 2000,49(suppl 1) :A434.
9Georgopoulos A, Aras O, Tsai M Y. Interaction of type 2 diabetes with the codon 54 polymorphism of the fatty acid binding protein 2 gene leads to hypertriglyceridemia[J]. Diabetes,2000,49(suppl 1): 83.
10Kousta E, Huxtable S, Saker P, et al. Sulfonylurea receptor-1 gene variants show no association with type 2 diabetes in north European populations when analysed using family-based association methods [J].Diabetes, 2000,40 (suppl 1): A203.
